XT
CNTX icon

XTX Topco’s Context Therapeutics CNTX Stock Holding History

XTX Topco’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Buy
+294,301
New +$597K ﹤0.01% 3351
2026
Q1 		– Sell
-101,605
Closed -$149K – 3903
2025
Q4 		$149K Buy
101,605
+91,008
+859% +$106K ﹤0.01% 2500
2025
Q3 		$10.3K Buy
+10,597
New +$8.59K ﹤0.01% 2441
2025
Q2 		– Sell
-15,673
Closed -$9.59K – 2469
2025
Q1 		$9.59K Buy
+15,673
New +$13.6K ﹤0.01% 2255
2024
Q2 		– Sell
-10,261
Closed -$14.2K – 1957
2024
Q1 		$14.2K Buy
+10,261
New +$11.5K ﹤0.01% 1642
2023
Q4 		– Sell
-13,259
Closed -$20K – 1674
2023
Q3 		$20K Buy
+13,259
New +$15K ﹤0.01% 1373

Other funds holding CNTX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

XTX Topco's CNTX Position: Q2 2026 in Review

XTX Topco opened a new position in Context Therapeutics (CNTX) in Q2 2026: 294,301 shares worth $163K. The stake represents ﹤0.01% of the portfolio and ranks #3351 among its holdings. This is a return to the name: XTX Topco previously reported a position in CNTX as recently as Q4 2025.

XTX Topco first reported a position in CNTX in Q3 2023 and has held it in 6 quarters since. 79 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • XTX Topco held 294,301 shares of Context Therapeutics worth $163K as of Q2 2026.
  • Context Therapeutics was a new XTX Topco position in Q2 2026.
  • Context Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3351 holding.
  • XTX Topco first reported a position in Context Therapeutics in Q3 2023 and has held it in 6 quarters since.
  • 79 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.